Tag: Pharmaceutical Industry

Martin Shkreli, the drug CEO, said Tuesday that he was told that he was targeted by government authorities because he was too "flamboyant." (AP Photo/Seth Wenig)

Martin Shkreli: I was targeted for being ‘flamboyant and personable’

Pete Kasperowicz · August 15, 2017 1:06 pm

Shares of pharmaceutical giant Merck rose slightly Monday morning after President Trump slammed high drug prices in response to the company's CEO resigning from the White House's manufacturing council. (AP Photo/Mel Evans)

The Trump bump: Merck shares rise after tweet

Kimberly Leonard · August 14, 2017 3:15 pm

"Now that Ken Frazier of Merck Pharma has resigned from President's Manufacturing Council, he will have more time to LOWER RIPOFF DRUG PRICES!" Trump tweeted. (AP Photo/Evan Vucci)

Trump slams Merck’s ‘ripoff drug prices’ after CEO resigns from manufacturing council

Melissa Quinn · August 14, 2017 1:11 pm

New Hampshire on Tuesday became the latest state to launch a lawsuit against a prescription painkiller manufacturer, Perdue Pharma, for deceptively marketing OxyContin. (AP Photo/Toby Talbot, File)

New Hampshire sues opioid makers for deceptive marketing

Kimberly Leonard · August 9, 2017 3:39 pm

Shkreli is charged with using an investment fund to prop up the earnings for the Retrophin. (AP Photo/Susan Walsh, File)

Martin Shkreli leaves a legacy on Capitol Hill

Robert King · August 5, 2017 12:22 am

‘Pharma Bro’ Martin Shkreli found guilty of securities fraud

‘Pharma Bro’ Martin Shkreli found guilty of securities fraud

Robert King · August 4, 2017 6:52 pm

The bill reauthorizes the FDA's program through which it charges fees for new drug or device applications. (iStock photo)

Senate passes FDA funding package

Robert King · August 3, 2017 4:47 pm

The bill would allow terminally ill patients the right to try experimental treatments that have not been approved when no alternatives exist. (iStock photo)

Senate passes bill to give terminally ill patients access to experimental drugs

Robert King · August 3, 2017 4:18 pm

Premiums for Medicare's Part D prescription drug program are expected to slightly decline in 2018, the first drop in five years, the Trump administration said Wednesday. (AP Photo/Jon Elswick)

Medicare Part D premiums set to drop next year

Robert King · August 2, 2017 9:43 pm

It is clear that neither party is willing to work with the other in order to create a better healthcare alternative. All the while, patients are suffering -- limited access and expensive premiums have isolated many. (C-SPAN2 via AP)

Beltway Confidential

Broken promises: Congress has let down patients and doctors in failing to fix Obamacare

Kevin Campbell · July 25, 2017 9:50 pm

Rather than giving companies new tax breaks or a cut in their overall tax rate, the focus of tax reform should be to completely clean out the code of all the special interest tax breaks and loopholes that companies such as Mylan take advantage of. (Victor J. Blue/Bloomberg)

Mylan: The poster child of what is wrong with the tax code

Washington Examiner Staff · July 24, 2017 4:01 am

"No longer will we allow other countries to break the rules, steal our jobs, and drain our wealth," President Trump said. "Instead, we will follow two simple but very crucial rules: We will buy American, and we will hire American." (AP Photo/Susan Walsh, File)

Trump touts ‘Made in America’

Josh Siegel · July 21, 2017 10:40 pm